litlas
Log inCreate account

John R. Wunderlich

Active 1964–2019

55
Papers
30,986
Citations
55
h-index
55
i10-index

Citations

Citations per year for John R. Wunderlich1965: 6 citations1966: 3 citations1967: 1 citations1968: 2 citations1969: 2 citations1971: 7 citations1972: 12 citations1973: 6 citations1974: 11 citations1975: 11 citations1976: 2 citations1977: 8 citations1978: 9 citations1979: 8 citations1980: 5 citations1981: 9 citations1982: 5 citations1984: 8 citations1985: 4 citations1986: 4 citations1987: 4 citations1988: 4 citations1989: 7 citations1990: 6 citations1991: 2 citations1992: 2 citations1993: 3 citations1994: 7 citations1995: 3 citations1996: 3 citations1997: 3 citations1998: 2 citations1999: 5 citations2000: 11 citations2001: 24 citations2002: 40 citations2003: 79 citations2004: 114 citations2005: 132 citations2006: 151 citations2007: 176 citations2008: 228 citations2009: 221 citations2010: 334 citations2011: 320 citations2012: 369 citations2013: 447 citations2014: 326 citations2015: 551 citations2016: 488 citations2017: 568 citations2018: 579 citations2019: 1,222 citations2020: 1,245 citations2021: 1,256 citations2022: 954 citations2023: 697 citations2024: 880 citations2025: 467 citations2026: 8 citations1970: no citations, so this year is not shown1983: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,592 citing papers, 36% of this breakdownChina: 1,130 citing papers, 11.3% of this breakdownGermany: 561 citing papers, 5.6% of this breakdownUnited Kingdom: 530 citing papers, 5.3% of this breakdownItaly: 369 citing papers, 3.7% of this breakdownFrance: 324 citing papers, 3.3% of this breakdownNetherlands: 321 citing papers, 3.2% of this breakdownJapan: 282 citing papers, 2.8% of this breakdownSwitzerland: 281 citing papers, 2.8% of this breakdownAustralia: 270 citing papers, 2.7% of this breakdownCanada: 242 citing papers, 2.4% of this breakdownSpain: 206 citing papers, 2.1% of this breakdown
0%36%Other 18.8%

Institutions

Fields

  • Medicine61.3%
  • Immunology and Microbiology24.4%
  • Biochemistry, Genetics and Molecular Biology12.4%
  • Engineering0.6%
  • Mathematics0.5%
  • Neuroscience0.3%
  • Other0.5%

Topics

  • CAR-T cell therapy research15.9%
  • Immunotherapy and Immune Responses15.4%
  • Cancer Immunotherapy and Biomarkers12.7%
  • Immune Cell Function and Interaction9.4%
  • T-cell and B-cell Immunology3.9%
  • Virus-based gene therapy research3.5%
  • Other39.2%

Coauthors

All papers

Open in search
  1. Durable Complete Responses in Heavily Pretreated Patients with Metastatic Melanoma Using T-Cell Transfer Immunotherapy

    Authors: Steven A. Rosenberg, James Chih‐Hsin Yang, Richard M. Sherry, Udai S. Kammula, Marybeth S. Hughes, Giao Q. Phan, Deborah E. Citrin, Nicholas P. Restifo, Paul F. Robbins, John R. Wunderlich, Kathleen E. Morton, Carolyn M. Laurençot, Seth M. Steinberg, Donald E. White, Mark E. Dudley - Clinical Cancer Research 2011 cited by 2,120

  2. Cancer Immunotherapy Based on Mutation-Specific CD4+ T Cells in a Patient with Epithelial Cancer

    Authors: Eric Tran, Simon Turcotte, Alena Gros, Paul F. Robbins, Yong‐Chen Lu, Mark E. Dudley, John R. Wunderlich, Robert Somerville, Katherine Hogan, Christian S. Hinrichs, Maria R. Parkhurst, James C. Yang, Steven A. Rosenberg - Science 2014 cited by 1,733

  3. Tumor antigen–specific CD8 T cells infiltrating the tumor express high levels of PD-1 and are functionally impaired

    Authors: Mojgan Ahmadzadeh, Laura A. Johnson, Bianca Heemskerk, John R. Wunderlich, Mark E. Dudley, Donald E. White, Steven A. Rosenberg - Blood 2009 cited by 1,759

  4. PD-1 identifies the patient-specific CD8+ tumor-reactive repertoire infiltrating human tumors

    Authors: Alena Gros, Paul F. Robbins, Xin Yao, Yong F. Li, Simon Turcotte, Eric Tran, John R. Wunderlich, Arnold Mixon, Shawn Farid, Mark E. Dudley, Ken‐ichi Hanada, Jorge R. Almeida, Samuel Darko, Daniel C. Douek, James Chih‐Hsin Yang, Steven A. Rosenberg - Journal of Clinical Investigation 2014 cited by 1,108

  5. A Phase I Study on Adoptive Immunotherapy Using Gene-Modified T Cells for Ovarian Cancer

    Authors: Michael H. Kershaw, Jennifer A. Westwood, Linda L. Parker, Gang Wang, Zelig Eshhar, Sharon Mavroukakis, Donald E. White, John R. Wunderlich, Silvana Canevari, Linda Rogers-Freezer, Clara C. Chen, James C. Yang, Steven A. Rosenberg, Patrick Hwu - Clinical Cancer Research 2006 cited by 1,239

  6. Cancer Regression in Patients After Transfer of Genetically Engineered Lymphocytes

    Authors: Richard A. Morgan, Mark E. Dudley, John R. Wunderlich, Marybeth S. Hughes, James Chih‐Hsin Yang, Richard M. Sherry, Richard E. Royal, Suzanne L. Topalian, Udai S. Kammula, Nicholas P. Restifo, Zhili Zheng, Azam Nahvi, Christiaan R. de Vries, Linda Rogers-Freezer, Sharon Mavroukakis, Steven A. Rosenberg - Science 2006 cited by 2,586

  7. Complete Regression of Metastatic Cervical Cancer After Treatment With Human Papillomavirus–Targeted Tumor-Infiltrating T Cells

    Authors: Sanja Stevanović, Lindsey M. Draper, Michelle M. Langhan, Tracy E. Campbell, Mei Li M. Kwong, John R. Wunderlich, Mark E. Dudley, James Chih‐Hsin Yang, Richard M. Sherry, Udai S. Kammula, Nicholas P. Restifo, Steven A. Rosenberg, Christian S. Hinrichs - Journal of Clinical Oncology 2015 cited by 677

  8. A Pilot Trial Using Lymphocytes Genetically Engineered with an NY-ESO-1–Reactive T-cell Receptor: Long-term Follow-up and Correlates with Response

    Authors: Paul F. Robbins, Sadik H. Kassim, Thai L.N. Tran, Jessica S. Crystal, Richard A. Morgan, Steven A. Feldman, James Chih‐Hsin Yang, Mark E. Dudley, John R. Wunderlich, Richard M. Sherry, Udai S. Kammula, Marybeth S. Hughes, Nicholas P. Restifo, Mark Raffeld, Chyi‐Chia Richard Lee, Yong F. Li, Mona El‐Gamil, Steven A. Rosenberg - Clinical Cancer Research 2014 cited by 801

  9. Immunogenicity of somatic mutations in human gastrointestinal cancers

    Authors: Eric Tran, Mojgan Ahmadzadeh, Yong‐Chen Lu, Alena Gros, Simon Turcotte, Paul F. Robbins, Jared J. Gartner, Zhili Zheng, Yong F. Li, Satyajit Ray, John R. Wunderlich, Robert Somerville, Steven A. Rosenberg - Science 2015 cited by 739

  10. Tumor Regression in Patients With Metastatic Synovial Cell Sarcoma and Melanoma Using Genetically Engineered Lymphocytes Reactive With NY-ESO-1

    Authors: Paul F. Robbins, Richard A. Morgan, Steven A. Feldman, James C. Yang, Richard M. Sherry, Mark E. Dudley, John R. Wunderlich, Azam Nahvi, Lee J. Helman, Crystal L. Mackall, Udai S. Kammula, Marybeth S. Hughes, Nicholas P. Restifo, Mark Raffeld, Chyi‐Chia Richard Lee, Catherine Lévy, Yong F. Li, Mona El‐Gamil, Susan Schwarz, Carolyn M. Laurençot, Steven A. Rosenberg - Journal of Clinical Oncology 2011 cited by 1,610

  11. Unique Neoantigens Arise from Somatic Mutations in Patients with Gastrointestinal Cancers

    Authors: Maria R. Parkhurst, Paul F. Robbins, Eric Tran, Todd D. Prickett, Jared J. Gartner, Lee Jia, Gabriel D. Ivey, Yong F. Li, Mona El‐Gamil, Almin Lalani, Jessica S. Crystal, Abraham Sachs, Eric Groh, Satyajit Ray, Lien T. Ngo, Scott Kivitz, Anna Pasetto, Rami Yossef, Frank J. Lowery, Stephanie L. Goff, Winifred Lo, Gal Cafri, Drew C. Deniger, Parisa Malekzadeh, Mojgan Ahmadzadeh, John R. Wunderlich, Robert Somerville, Steven A. Rosenberg - Cancer Discovery 2019 cited by 296

  12. Randomized, Prospective Evaluation Comparing Intensity of Lymphodepletion Before Adoptive Transfer of Tumor-Infiltrating Lymphocytes for Patients With Metastatic Melanoma

    Authors: Stephanie L. Goff, Mark E. Dudley, Deborah E. Citrin, Robert Somerville, John R. Wunderlich, David N. Danforth, Daniel Zlott, James Chih‐Hsin Yang, Richard M. Sherry, Udai S. Kammula, Christopher A. Klebanoff, Marybeth S. Hughes, Nicholas P. Restifo, Michelle M. Langhan, Thomas E. Shelton, Lily Lu, Mei Li M. Kwong, Sadia Ilyas, Nicholas D. Klemen, Eden C. Payabyab, Kathleen E. Morton, Mary Ann Toomey, Seth M. Steinberg, Donald E. White, Steven A. Rosenberg - Journal of Clinical Oncology 2016 cited by 402

  13. Prospective identification of neoantigen-specific lymphocytes in the peripheral blood of melanoma patients

    Authors: Alena Gros, Maria R. Parkhurst, Eric Tran, Anna Pasetto, Paul F. Robbins, Sadia Ilyas, Todd D. Prickett, Jared J. Gartner, Jessica S. Crystal, Ilana M. Roberts, Kasia Trebska-McGowan, John R. Wunderlich, James Chih‐Hsin Yang, Steven A. Rosenberg - Nature Medicine 2016 cited by 844

  14. Cancer Regression and Autoimmunity in Patients After Clonal Repopulation with Antitumor Lymphocytes

    Authors: Mark E. Dudley, John R. Wunderlich, Paul F. Robbins, James Chih‐Hsin Yang, Patrick Hwu, Douglas J. Schwartzentruber, Suzanne L. Topalian, Richard M. Sherry, Nicholas P. Restifo, Amy M. Hubicki, Michael R. Robinson, Mark Raffeld, Paul H. Duray, Claudia A. Seipp, Linda Rogers-Freezer, Kathleen E. Morton, Sharon Mavroukakis, Donald E. White, Steven A. Rosenberg - Science 2002 cited by 2,828

  15. A Phase II Study of Tumor-infiltrating Lymphocyte Therapy for Human Papillomavirus–associated Epithelial Cancers

    Authors: Sanja Stevanović, Sarah R. Helman, John R. Wunderlich, Michelle M. Langhan, Stacey L. Doran, Mei Li M. Kwong, Robert Somerville, Christopher A. Klebanoff, Udai S. Kammula, Richard M. Sherry, James Chih‐Hsin Yang, Steven A. Rosenberg, Christian S. Hinrichs - Clinical Cancer Research 2018 cited by 293

  16. Adoptive Cell Therapy for Patients With Metastatic Melanoma: Evaluation of Intensive Myeloablative Chemoradiation Preparative Regimens

    Authors: Mark E. Dudley, James Chih‐Hsin Yang, Richard M. Sherry, Marybeth S. Hughes, Richard E. Royal, Udai S. Kammula, Paul F. Robbins, JianPing Huang, Deborah E. Citrin, Susan F. Leitman, John R. Wunderlich, Nicholas P. Restifo, Armen A. Thomasian, Stephanie G. Downey, Franz O. Smith, Jacob A. Klapper, Kathleen E. Morton, Carolyn M. Laurençot, Donald E. White, Steven A. Rosenberg - Journal of Clinical Oncology 2008 cited by 1,330

  17. Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigen

    Authors: Laura A. Johnson, Richard A. Morgan, Mark E. Dudley, Lydie Cassard, James C. Yang, Marybeth S. Hughes, Udai S. Kammula, Richard E. Royal, Richard M. Sherry, John R. Wunderlich, Chyi‐Chia Richard Lee, Nicholas P. Restifo, Susan Schwarz, Alexandria P. Cogdill, Rachel Bishop, Hung Kim, Carmen C. Brewer, Susan F. Rudy, Carter VanWaes, Jeremy L. Davis, Aarti Mathur, R. Taylor Ripley, Debbie Nathan, Carolyn M. Laurençot, Steven A. Rosenberg - Blood 2009 cited by 1,406

  18. Adoptive Cell Transfer Therapy Following Non-Myeloablative but Lymphodepleting Chemotherapy for the Treatment of Patients With Refractory Metastatic Melanoma

    Authors: Mark E. Dudley, John R. Wunderlich, James Chih‐Hsin Yang, Richard M. Sherry, Suzanne L. Topalian, Nicholas P. Restifo, Richard E. Royal, Udai S. Kammula, D E White, Sharon Mavroukakis, Linda Rogers, Gerald Gracia, Stephanie A. Jones, David P. Mangiameli, Michelle M. Pelletier, Juan Gea‐Banacloche, Michael R. Robinson, David M. Berman, Armando Filie, Andrea Abati, Steven A. Rosenberg - Journal of Clinical Oncology 2005 cited by 1,628

  19. Generation of Tumor-Infiltrating Lymphocyte Cultures for Use in Adoptive Transfer Therapy for Melanoma Patients

    Authors: Mark E. Dudley, John R. Wunderlich, Thomas E. Shelton, Jos Even, Steven A. Rosenberg - Journal of Immunotherapy 2003 cited by 709

  20. Treatment of metastatic uveal melanoma with adoptive transfer of tumour-infiltrating lymphocytes: a single-centre, two-stage, single-arm, phase 2 study

    Authors: Smita S. Chandran, Robert Somerville, James C. Yang, Richard M. Sherry, Christopher A. Klebanoff, Stephanie L. Goff, John R. Wunderlich, David N. Danforth, Daniel Zlott, Biman C. Paria, Arvind Sabesan, Abhishek K. Srivastava, Liqiang Xi, Trinh Pham, Mark Raffeld, Donald E. White, Mary Ann Toomey, Steven A. Rosenberg, Udai S. Kammula - The Lancet Oncology 2017 cited by 288

  21. CD8+ Enriched “Young” Tumor Infiltrating Lymphocytes Can Mediate Regression of Metastatic Melanoma

    Authors: Mark E. Dudley, Colin Gross, Michelle M. Langhan, Marcos Ríos García, Richard M. Sherry, James C. Yang, Giao Q. Phan, Udai S. Kammula, Marybeth S. Hughes, Deborah E. Citrin, Nicholas P. Restifo, John R. Wunderlich, Peter A. Prieto, Jenny J. Hong, Russell C. Langan, Daniel Zlott, Kathleen E. Morton, Donald E. White, Carolyn M. Laurençot, Steven A. Rosenberg - Clinical Cancer Research 2010 cited by 316

  22. Selection of CD8+PD-1+ Lymphocytes in Fresh Human Melanomas Enriches for Tumor-reactive T Cells

    Authors: Takashi Inozume, Ken‐ichi Hanada, Qiong J. Wang, Mojgan Ahmadzadeh, John R. Wunderlich, Steven A. Rosenberg, James C. Yang - Journal of Immunotherapy 2010 cited by 232

  23. Minimally Cultured Tumor-infiltrating Lymphocytes Display Optimal Characteristics for Adoptive Cell Therapy

    Authors: Khoi Q. Tran, Juhua Zhou, Katherine H. Durflinger, Michelle M. Langhan, Thomas E. Shelton, John R. Wunderlich, Paul F. Robbins, Steven A. Rosenberg, Mark E. Dudley - Journal of Immunotherapy 2008 cited by 290

  24. Randomized Selection Design Trial Evaluating CD8+-Enriched Versus Unselected Tumor-Infiltrating Lymphocytes for Adoptive Cell Therapy for Patients With Melanoma

    Authors: Mark E. Dudley, Colin Gross, Robert Somerville, Young Ki Hong, Nicholas P. Schaub, Shannon F. Rosati, Donald E. White, Debbie Nathan, Nicholas P. Restifo, Seth M. Steinberg, John R. Wunderlich, Udai S. Kammula, Richard M. Sherry, James Chih‐Hsin Yang, Giao Q. Phan, Marybeth S. Hughes, Carolyn M. Laurençot, Steven A. Rosenberg - Journal of Clinical Oncology 2013 cited by 231